EcoDrugPlus

Integrin Subunit Alpha 4

Ensembl ID : ENSPKIG00000021441
Gene Symbol: ITGA4
3 Cross references
224 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSPKIG00000019163
Gene Symbol: ITGA5
4 Cross references
197 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSPKIG00000022190
Gene Symbol: ITGAV
3 Cross references
236 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSPKIG00000020653
Gene Symbol: ITGB1
3 Cross references
297 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSPKIG00000011335
Gene Symbol: ITGB1
2 Cross references
297 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSPKIG00000022558
Gene Symbol: ITGB3
3 Cross references
194 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSPKIG00000021035
Gene Symbol: ITGB5
3 Cross references
210 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSPKIG00000001575
Gene Symbol: ITGB6
3 Cross references
206 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSPKIG00000023246
Gene Symbol: ITGB7
3 Cross references
150 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSPKIG00000022705
Gene Symbol: ITGB8
3 Cross references
202 Possible Orthologues:

Integrin, Alpha 5 (Fibronectin Receptor, Alpha Polypeptide)

Ensembl ID : ENSPKIG00000014956
Gene Symbol: ITGA5
1 Cross references
206 Possible Orthologues:

Integrin, Alpha V

Ensembl ID : ENSPKIG00000009465
Gene Symbol: ITGAV
1 Cross references
236 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).